Prevalencia y Factores Asociados a la Prescripción Inapropiada de Omeprazol en Adultos Mayores, Referidos de la Consulta Externa al Módulo de Geriatría: Estudio Transversal
Objective: To determine the prevalence of inappropriate prescription of omeprazole in older adults, referred from the outpatient clinic to the Geriatrics module of a second level Hospital. Methods: cross-sectional, analytical, retrospective study, during October 2021 to October 2022. It included 172...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | español |
| Publicado: |
2024
|
| Materias: | |
| Acceso en línea: | https://dialnet.unirioja.es/servlet/oaiart?codigo=9430139 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Objective: To determine the prevalence of inappropriate prescription of omeprazole in older adults, referred from the outpatient clinic to the Geriatrics module of a second level Hospital. Methods: cross-sectional, analytical, retrospective study, during October 2021 to October 2022. It included 172 patients ≥65 years old, obtained through non-probabilistic convenience sampling. The source of information was the electronic clinical record, from which the sociodemographic and clinical variables were obtained. The PPI of omeprazole was determined using the STOPP-START criteria. Descriptive statistics, bivariate analysis and logistic regression were performed with the data obtained. Results: 97.9% presented a PPI of omeprazole, 86.6% of older adults had at least one geriatric syndrome, polypharmacy was the most frequent with 72.1%. An association was detected with polypharmacy (OR=3.46, 95% CI 1.74-6.90) and dementia (OR=0.45, 95% CI 0.24-6.84). Conclusion: nine out of ten older adults received a PPI of omeprazole, while more than half of the study sample presented polypharmacy. Medical personnel must ensure safe, evidence-based prescription to prevent possible side effects. |
|---|